$76.32
-0.590 (-0.767%)
At Close: Aug 04, 2026
These 2 Stocks Just Hit a New 52-Week High. Time to Bail?
11:00am, Monday, 16'th Sep 2024
“Let your winners run.” Most investors have heard that sage advice even if it is easier said than done.
Billionaire Investor Warns Of 'Worst Outcome' Economy Possible: Our Approach
07:05am, Monday, 16'th Sep 2024
A prominent billionaire recently warned of the plausibility of the worst-case scenario for the U.S. economy playing out. We discuss why we think there is a reasonable chance of this happening as well.
Agree Realty: The Multiple Expansion Has Not Made The Case Unattractive
11:26pm, Sunday, 15'th Sep 2024
Since my earlier piece this June on Agree Realty, the total return performance has landed at close to 25%. This has expanded ADC's multiple quite a lot, and consequently brought down the yield to belo
If I Could Only Hold 5 REITs Over The Next Decade
09:00am, Saturday, 14'th Sep 2024
I often hold my REITs for just 1-2 years. But there are some exceptions that we expect to hold for the long run. Here 5 REITs that I will hold for the next decade.
3 No-Brainer High-Yield Stocks to Buy With $200 Right Now
03:06am, Friday, 13'th Sep 2024
Net lease real estate investment trusts require tenants to pay most property-level operating expenses. Although any one location is high-risk for a net lease REIT, those with large portfolios tend to
2 REITs Most Investors Should Own
08:15am, Thursday, 12'th Sep 2024
There is a minority of REITs that check all the boxes. High yield, steady growth, lower risk, and upside potential. I discuss 2 such REITs that most investors should consider.
Sutro Biopharma to Host Research Forum Highlighting Next-Generation ADC Innovation and Near-term Pipeline, on October 10, 2024
08:00am, Wednesday, 11'th Sep 2024
SOUTH SAN FRANCISCO, Calif., Sept. 11, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format
Agree Realty Declares Monthly Common and Preferred Dividends
04:05pm, Tuesday, 10'th Sep 2024
ROYAL OAK, Mich. , Sept. 10, 2024 /PRNewswire/ -- Agree Realty Corporation (NYSE: ADC) (the "Company") today announced that its Board of Directors has authorized, and the Company has declared, a mont
Places You Routinely Visit Could Provide You With a Pathway Toward a Lifetime of Passive Income
06:50am, Sunday, 08'th Sep 2024
Agree Realty owns retail properties, like grocery stores and home improvement locations. Getty Realty owns gas stations and other auto-related convenience properties.
10 SWANs For The Next Black Swan
07:00am, Saturday, 07'th Sep 2024
I focus on bottom-up analysis, identifying companies with strong operational performance and balance sheets that can weather Black Swan events, regardless of stock market fluctuations. Realty Income,
How I Would Invest $100,000 For Big Dividends In September 2024
07:05am, Friday, 06'th Sep 2024
I discuss which areas of the market are most opportunistic for generating high yield income right now. I share some of my top picks within those sectors. I also share how I would deploy $100,000 of ne
Nurix Therapeutics To Participate in Upcoming ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit
07:00am, Friday, 06'th Sep 2024
SAN FRANCISCO, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat pat
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
04:05pm, Tuesday, 03'rd Sep 2024
LAUSANNE, Switzerland, Sept. 03, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announce
Rates Down, REITs Up: Two Quality REITs To Own For Long-Term Gains
08:45am, Tuesday, 03'rd Sep 2024
Agree Realty and CareTrust REIT share prices have rallied since July due to cooling inflation. Additionally, both offer long-term upside due to high-quality business models and strong fundamentals. Ag
ADC Therapeutics to Present at Upcoming Investor Conferences
07:15am, Tuesday, 03'rd Sep 2024
LAUSANNE, Switzerland, Sept. 03, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announce
Sign In
Buy ADC